CGHMC acquires top innovations in urology
Dr. James Dy, president of Chinese General Hospital and Medical Center (CGHMC) owned and operated by Philippine Chinese Charitable Association Inc. (PCCAI) recently acquired the world’s first Koelis Trinity fusion biopsy technology (with transperineal probe for clinical use) and state-of-the-art BK 5000 and BK 3000 ultrasound systems. The new innovations were blessed and launched last Aug. 17.
The Koelis Trinity fusion biopsy technology machine from Transmedic Philippines will assist CGHMC in steering a revolution in detection and management of prostate cancer.
It allows for an unmatched superiority in the localization of prostate cancers. It also provides access to tumors located in deep areas of the prostate gland, previously regarded as inaccessible and beyond the reach of standard biopsy.
The explosion of medical information and application of computer technology led to the creation of a new and amazingly accurate diagnostic technique using fused ultrasound and MRI imaging, and it is poised to supersede the old biopsy technique.
The first transperineal fusion biopsy was performed by CGHMC Urology director Jason Letran last May 13. Since then, the accumulated results prove that the new technology is superior.
With its accuracy, effectiveness and patient safety, the procedure will be the new gold standard in prostate cancer detection today and in years to come.
CGHMC has also recently acquired the state-ofthe-art BK 5000 and BK 3000 ultrasound systems from AAA Pharma Inc.
Again, the hospital is the first in the country to own the advance technologies. The two ultrasound machines are fully equipped with six different probes that cover various surgical disciplines and various parts of the human body.
The two transrectal probes allow for diagnostic as well as therapeutic prostate procedures.
The other probes allow access to various structures such as breast, thyroid, blood vessels, the genito-urinary tract and the hepato-biliary system.
It provides unmatched clarity of images, allowing not only for more efficient diagnostic, but also therapeutic procedures such as radiofrequency ablation in management of liver cancer, brachytherapy for prostate cancer, percutaneous access to the urinary tract and blood vessels for vascular access.
It likewise has an intraoperative and laparoscopic probe for accurate localization of tumors to be resected during a surgical procedure.
CGHMC and its Institute of Urology continue to aim for the best and latest technology for holistic approach in patient care.
It is a privilege to acquire the Koelis Trinity and the BK 5000 and 3000 ultrasound systems as a milestone in medical field.
This institution humbly shares this advancement to uplift the lives of the general public.